Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, Zwick MB, Phogat SK, Poignard P, Burton DR.

PLoS Pathog. 2010 Aug 5;6(8):e1001028. doi: 10.1371/journal.ppat.1001028.

PMID:
20700449
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antibody epitope exposure and neutralization of HIV-1.

Pantophlet R.

Curr Pharm Des. 2010;16(33):3729-43. Review.

PMID:
21128886
[PubMed - indexed for MEDLINE]
3.

Roles of HIV-1 Env variable regions in viral neutralization and vaccine development.

Pinter A.

Curr HIV Res. 2007 Nov;5(6):542-53. Review.

PMID:
18045110
[PubMed - indexed for MEDLINE]
4.

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.

Pollara J, Bonsignori M, Moody MA, Pazgier M, Haynes BF, Ferrari G.

Curr HIV Res. 2013 Jul;11(5):378-87. Review.

PMID:
24191939
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Challenges for structure-based HIV vaccine design.

Schief WR, Ban YE, Stamatatos L.

Curr Opin HIV AIDS. 2009 Sep;4(5):431-40. doi: 10.1097/COH.0b013e32832e6184. Review.

PMID:
20048708
[PubMed - indexed for MEDLINE]
6.

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

Haynes BF, Montefiori DC.

Expert Rev Vaccines. 2006 Jun;5(3):347-63. Review.

PMID:
16827619
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Neutralizing antibodies to HIV-1 induced by immunization.

McCoy LE, Weiss RA.

J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827. Review.

PMID:
23401570
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?

Montefiori DC, Mascola JR.

Curr Opin HIV AIDS. 2009 Sep;4(5):347-51. doi: 10.1097/COH.0b013e32832f4a4d. Review.

PMID:
20048696
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Specificity of the autologous neutralizing antibody response.

Moore PL, Gray ES, Morris L.

Curr Opin HIV AIDS. 2009 Sep;4(5):358-63. doi: 10.1097/COH.0b013e32832ea7e8. Review.

PMID:
20048698
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.

Kwong PD, Mascola JR, Nabel GJ.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007278. doi: 10.1101/cshperspect.a007278. Review.

PMID:
22229123
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Structure-based vaccine design in HIV: blind men and the elephant?

Pejchal R, Wilson IA.

Curr Pharm Des. 2010;16(33):3744-53. Review.

PMID:
21128885
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Phogat S, Wyatt RT, Karlsson Hedestam GB.

J Intern Med. 2007 Jul;262(1):26-43. Review.

PMID:
17598813
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Rational antibody-based HIV-1 vaccine design: current approaches and future directions.

Walker LM, Burton DR.

Curr Opin Immunol. 2010 Jun;22(3):358-66. doi: 10.1016/j.coi.2010.02.012. Epub 2010 Mar 17. Review.

PMID:
20299194
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Toward an antibody-based HIV-1 vaccine.

Hoxie JA.

Annu Rev Med. 2010;61:135-52. doi: 10.1146/annurev.med.60.042507.164323. Review.

PMID:
19824826
[PubMed - indexed for MEDLINE]
15.

The Antibody Response against HIV-1.

Overbaugh J, Morris L.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. doi: 10.1101/cshperspect.a007039. Review.

PMID:
22315717
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HIV-1 neutralizing antibodies: understanding nature's pathways.

Mascola JR, Haynes BF.

Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075. Review.

PMID:
23772623
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM.

Hum Antibodies. 2005;14(3-4):59-67. Review.

PMID:
16720975
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.

Chen W, Ying T, Dimitrov DS.

Expert Opin Biol Ther. 2013 May;13(5):657-71. doi: 10.1517/14712598.2013.761969. Epub 2013 Jan 7. Review.

PMID:
23293858
[PubMed - indexed for MEDLINE]
19.

Antibodies in HIV-1 vaccine development and therapy.

Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC.

Science. 2013 Sep 13;341(6151):1199-204. doi: 10.1126/science.1241144. Review.

PMID:
24031012
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Back to the future: covalent epitope-based HIV vaccine development.

Paul S, Planque S, Nishiyama Y, Escobar M, Hanson C.

Expert Rev Vaccines. 2010 Sep;9(9):1027-43. doi: 10.1586/erv.10.77. Review.

PMID:
20822346
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk